Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational St
For postmenopausal women with at least one vulvovaginal atrophy (VVA) symptom, the presence of physician-confirmed VVA is linked to significant impaired sexual function, according to a study from the European Vulvovaginal Epidemiological Survey (EVES).
Social inequalities impose negative impact in postmenopausal women with metabolic syndrome and osteoporosis
Social inequalities profoundly impact South Korean postmenopausal women who have metabolic syndrome and osteoporosis, according to a cross-sectional study in the journal Menopause.
The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.
New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.
A diagnosis of vulvovaginal atrophy (VVA) in breast cancer survivors is associated with a significant increase in the burden of illness and social costs.
Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms but not during their reported menopause transition, according to new research.
A study in Menopause found that a significant proportion of premenopausal and perimenopausal women experienced hot flashes after receiving breast cancer treatment.
New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).
Like some aspects of reproductive function, menopausal symptoms appear to exhibit seasonal variation, according to new research from Menopause.